Business
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™\nPR Newswire\nSAN DIEGO, Jan. 8, 2020\n\n\n\nSAN DIEGO, Jan. 8, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (\"Kannalife\") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, received a designated International Nomenclature Cosmetic Ingredient (INCI) name for its patent-pending molecule and flagship consumer product to be sold under the trademark Atopidine™. \nThe International Cosmetic Ingredient Nomenclature Committee assigned the INCI name \"Limonenyldihydroxybenzyl Ethoxycarbonyl Azetidine\" (\"LEA\") to Atopidine™, one of Kannalife's leading novel cannabidiol (CBD)-like molecules.\n\"For more than a decade we have been recognized as a leader in the cannabis industry and we plan to continue with such a reputation as our portfolio investment company Kannalife receives this internationally recognized name for its new CBD-like molecule,\" said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \"Research and innovation are at the top of our priority list and we look forward to witnessing the many breakthroughs Kannalife is able to achieve this year.\"\nINCI names are systematic names internationally recognized to identify cosmetic ingredients. They are developed by the International Nomenclature Committee (INC) and published by the Personal Care Products Council (PCPC) in the International Cosmetic Ingr...